Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now early-phase tilt small index

Joint Diseases: early-phase trial registry

2 of 10 indexed Joint Diseases trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #1,724 of 28,707 conditions by registered trial count.

10 US clinical trials · 2 currently recruiting · #1,724 of 28,707 conditions by registered trial count

Joint Diseases: 10 US clinical trials tracked, 2 recruiting.

Joint Diseases is the subject of 10 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Anderson Orthopaedic Research Institute, running 2 of these trials.

Enrollment posture brief

Registry condition joint-diseases

OPEN 2 | RECR 20% | LATE 0 | EARLY 1 | RANK #1724 | SPON 2

Nearest open-share peer: Acral Lentiginous Melanoma (20% recruiting · 5 trials)

Acute Leukemia of Ambiguous 80%Achondroplasia40%Accelerated Phase Chronic My20%Accidental Fall20%Joint Diseases (this)20%
Open-enrollment share among volume-matched conditions near Joint Diseases

Joint Diseases lists 2 open slots (20% of 10 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Joint Diseases on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Joint Diseases is recruiting below its size-band peers.

    2 of 10 indexed trials (20%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Joint Diseases research.

    Anderson Orthopaedic Research Institute accounts for 2 of 10 trials (20%). 9 distinct sponsors appear on at least one study for this condition label.

  3. Typical Joint Diseases enrolment sits around 160 participants.

    Median target enrolment is 160 among the 10 trials that report a genuine target (sentinel values excluded). 4 of those (40%) plan for fewer than 100 participants.

  4. Joint Diseases research is mostly interventional.

    7 interventional and 3 observational studies make up this index (70% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 21

Open and recent trials

10 total, page 1 of 1

Phase Distribution

PhaseTrial count
Phase 2 1

Named interventions

Most-linked intervention names on Joint Diseases records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Adjunctive use of lavender and peppermint essential oils Dietary supplement
1 trials
Hip Replacement with noncrosslinked Enduron polyethylene Device
1 trials
Hip Replacement with crosslinked Marathon polyethylene Device
1 trials
Total Hip Replacement Device
1 trials
Knee stability training Other
1 trials
Traditional exercise therapy for knee osteoarthritis Other
1 trials
SakuraBead Resorbable Microspheres Device
1 trials
EVOLUTION® NitrX™ Device
1 trials

US sites by state

Facility locations filed on Joint Diseases trials. A trial with sites in several states counts in each.

Ohio 4 trials
Virginia 3 trials
Illinois 2 trials
Florida 2 trials
California 2 trials
Pennsylvania 1 trials
North Carolina 1 trials
Indiana 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Joint Diseases page

10 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Joint Diseases condition card totals 10 registered trials; most-linked intervention Adjunctive use of lavender and peppermint essential oils; top US site state Ohio. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.